Status: Recruiting
Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome
The purpose of this Phase IIa study is to evaluate the safety, tolerability, and effectiveness of CTH120 in adult males with Fragile X syndrome.
Participants needed: 30
Trial details
Phase: Phase 2Age: 18-45Biological sex: MaleType: InterventionalSponsor: Connecta Therapeutics, S.L.Updated: Jun 17, 2026Locations: 2
Eligibility criteria
Adult male participants. [+11]
Personal history of infantile spasms/convulsions/epilepsy, severe head trauma or... [+15]